Dooley MA - Search Results

1

Autoantibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of scleroderma.

Stojanov L, Satoh M, Dooley MA, Kuwana M, Jennette JC, Reeves WH. Stojanov L, et al. Among authors: dooley ma. Lupus. 1995 Aug;4(4):314-7. doi: 10.1177/096120339500400414. Lupus. 1995. PMID: 8528230

2

Autoantibodies that stabilize the molecular interaction of Ku antigen with DNA-dependent protein kinase catalytic subunit.

Satoh M, Ajmani AK, Stojanov L, Langdon JJ, Ogasawara T, Wang J, Dooley MA, Richards HB, Winfield JB, Carter TH, Reeves WH. Satoh M, et al. Among authors: dooley ma. Clin Exp Immunol. 1996 Sep;105(3):460-7. doi: 10.1046/j.1365-2249.1996.d01-775.x. Clin Exp Immunol. 1996. PMID: 8809135 Free PMC article.

3

Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus.

Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS. Cooper GS, et al. Among authors: dooley ma. Arthritis Rheum. 1998 Oct;41(10):1714-24. doi: 10.1002/1529-0131(199810)41:10<1714::AID-ART3>3.0.CO;2-U. Arthritis Rheum. 1998. PMID: 9778212 Review. No abstract available.

4

Immunosuppressive therapy of lupus nephritis.

Dooley MA, Falk RJ. Dooley MA, et al. Lupus. 1998;7(9):630-4. doi: 10.1191/096120398678920767. Lupus. 1998. PMID: 9884101 Review.

5

Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States.

Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Cohen PL, Roubey RA, Dooley MA. Cooper GS, et al. Among authors: dooley ma. Lupus. 2002;11(3):161-7. doi: 10.1191/0961203302lu161oa. Lupus. 2002. PMID: 11999880

6

Occupational risk factors for the development of systemic lupus erythematosus.

Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Dooley MA. Cooper GS, et al. Among authors: dooley ma. J Rheumatol. 2004 Oct;31(10):1928-33. J Rheumatol. 2004. PMID: 15468355

7

CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States.

Parks CG, Hudson LL, Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP. Parks CG, et al. Among authors: dooley ma. Lupus. 2004;13(10):784-91. doi: 10.1191/0961203304lu1085oa. Lupus. 2004. PMID: 15540511

8

Review of ACR renal criteria in systemic lupus erythematosus.

Dooley MA, Aranow C, Ginzler EM. Dooley MA, et al. Lupus. 2004;13(11):857-60. doi: 10.1191/0961203304lu2023oa. Lupus. 2004. PMID: 15580982

9

Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype.

Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP. Parks CG, et al. Among authors: dooley ma. Arthritis Rheum. 2005 Apr;52(4):1148-59. doi: 10.1002/art.20997. Arthritis Rheum. 2005. PMID: 15818712 Free article.

10

Mycophenylate mofetil: what role in the treatment of lupus?

Dooley MA. Dooley MA. Lupus. 2006;15(3):179-82. doi: 10.1191/0961203306lu2294rr. Lupus. 2006. PMID: 16634373 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters